This site is intended for UK healthcare professionals only and contains promotional information.UK Flag Please visit the MHRA Yellowcard site to report an Adverse Event.

ABPI Values

ABPI Values

Menarini operates within the four ABPI principles, adhering to these values internally within our culture and externally in our interactions with all stakeholders.

Patient focus

We provide a range of products to treat a variety of conditions. To ensure patient safety, we act on all Adverse Event (AE) reports promptly. We only promote our prescription medications to Healthcare professionals (HCPs), to ensure all HCPs are aware of the treatment options that are available for their patients.

  • A range of products to treat a variety of conditions
  • AE reports are acted on promptly
  • We only promote to HCPs

Integrity

We hold ourselves to high standards in our internal and external interactions. All our promotional materials are factual and accurate. Our business is conducted honestly, and we will not take part in actions that will give us an unfair advantage in the decision making process of any individuals or organisations.

  • We hold our staff and professional relationships to a high standard
  • All our communications are accurate, honest and factual
  • We do not offer payments or take part in any actions that will influence decision makers to give us an unfair advantage in any circumstances

Transparency

Our involvement with HCPs and event organisers during meetings and presentations are made clear from the start. All our transactions are transparent and held on record.

Respect

We treat both internal and external stakeholders with respect, as we recognise the importance of creating a respectful environment within the industry. We also value the importance of independent decision making by those we interact with.

  • We treat both our internal and external stakeholders with respect
  • We recognise the importance of creating a respectful environment within the industry
  • We respect the decisions made by all those we interact with

PP-MN-UK-0547 January 2024

Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store.

Adverse events should also be reported to A. Menarini Farmaceutica Internazionale SRL.

Phone 0800 085 8678